Target intelligence / Profile preview

RNA 2'-O-methyltransferase fibrillarin-like protein 1 (FBLL1)

Target
FBLL1
Molecular classification
Enzyme, RNA 2'-O-methyltransferase, small nucleolar ribonucleoprotein (snoRNP) component
01

Overview

RNA 2'-O-methyltransferase fibrillarin-like protein 1 (FBLL1) is a neuron-specific enzyme that belongs to the class of small nucleolar ribonucleoprotein (snoRNP) 2'-O-methyltransferases[1][2][4][7]. It catalyzes the transfer of methyl groups to the ribose 2'-hydroxyl position of RNA nucleotides, a modification implicated in mRNA stability and function. Unlike the canonical fibrillarin (FBL), FBLL1 has distinct substrate preferences and is predominantly expressed in brain and neuronal cells, where it is essential for 2'-O-methylation of GAP43 mRNA and thus, for neuronal differentiation. Knockdown of FBLL1 impairs RNA methylation and inhibits neuronal differentiation, suggesting a specialized role in neurodevelopment[1][2][4][7][8]. There is currently no reported evidence of drug interactions, biomarker utility, or specific safety concerns related to FBLL1.

Other names
Fibrillarin like 1RNA 2'-O-methyltransferase FBLL1LOC345630protein-glutamine methyltransferaserRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1FBLL1
02

Mechanism of action

Catalyzes 2'-O-methylation of ribose in RNA, especially in GAP43 mRNA, influencing neuronal differentiation

03

Biological functions

RNA modification (2'-O-methylation)Neuronal differentiationRegulation of messenger RNA stability
04

Disease associations

Neurodevelopmental diseasePotential relevance in neurological disordersOther

Beyond the preview

Go deeper on RNA 2'-O-methyltransferase fibrillarin-like protein 1 (FBLL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA 2'-O-methyltransferase fibrillarin-like protein 1 (FBLL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call